Veklury Use While Pregnant to be Studied

In COVID-19, Latest News by Precision Vaccinations

A recent study funded by the National Institutes of Health (NIH) will evaluate the effects of Veklury (remdesivir) in pregnant women who are being treated for COVID-19. 
This NIH study announced on February 17, 2021, aims to determine how pregnant women metabolize Veklury and any potential side effects.
The study will be conducted at 17 sites in the continental United States and Puerto Rico. It will be led by the NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.

Read More